NL293572A - - Google Patents

Info

Publication number
NL293572A
NL293572A NL293572DA NL293572A NL 293572 A NL293572 A NL 293572A NL 293572D A NL293572D A NL 293572DA NL 293572 A NL293572 A NL 293572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL293572A publication Critical patent/NL293572A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL293572D 1962-06-07 NL293572A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US200649A US3206470A (en) 1962-06-07 1962-06-07 Novel pyrrolo[1, 2-alpha]indoles

Publications (1)

Publication Number Publication Date
NL293572A true NL293572A (en:Method)

Family

ID=22742594

Family Applications (1)

Application Number Title Priority Date Filing Date
NL293572D NL293572A (en:Method) 1962-06-07

Country Status (8)

Country Link
US (1) US3206470A (en:Method)
AT (1) AT250951B (en:Method)
BE (1) BE633281A (en:Method)
BR (1) BR6349521D0 (en:Method)
DE (1) DE1445422A1 (en:Method)
ES (1) ES288785A1 (en:Method)
GB (1) GB1033253A (en:Method)
NL (1) NL293572A (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4134894A (en) * 1978-05-04 1979-01-16 Warner-Lambert Company Pyrrolo[1,2-a]indole compounds
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
WO2003082271A2 (en) 2002-04-03 2003-10-09 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
KR20170044760A (ko) 2008-07-23 2017-04-25 아레나 파마슈티칼스, 인크. 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[ｂ]인돌-3-일)아세트산 유도체
EA036955B1 (ru) 2008-08-27 2021-01-19 Арена Фармасьютикалз, Инк. Производные замещенных трициклических кислот в качестве агонистов рецептора s1p1, применимые при лечении аутоиммунных и воспалительных заболеваний
CN103221391B (zh) 2010-01-27 2018-07-06 艾尼纳制药公司 (R)-2-(7-(4-环戊基-3-(三氟甲基)苄基氧基)-1,2,3,4-四氢环戊二烯并[b]吲哚-3-基)乙酸及其盐的制备方法
CA2789480A1 (en) * 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
PT3310760T (pt) 2015-06-22 2022-11-10 Arena Pharm Inc Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
US11478448B2 (en) 2017-02-16 2022-10-25 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
CN112601516A (zh) 2018-06-06 2021-04-02 艾尼纳制药公司 治疗与s1p1受体相关的病况的方法
CN119751336A (zh) 2018-09-06 2025-04-04 艾尼纳制药公司 可用于治疗自身免疫性病症和炎性病症的化合物
CN110878099B (zh) * 2019-11-25 2021-11-30 五邑大学 一种吡咯[1,2,α]吲哚生物碱衍生物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707187A (en) * 1952-07-14 1955-04-26 Upjohn Co Chemical process

Also Published As

Publication number Publication date
DE1445422A1 (de) 1969-04-10
GB1033253A (en) 1966-06-22
US3206470A (en) 1965-09-14
BE633281A (fr) 1963-12-05
AT250951B (de) 1966-12-12
BR6349521D0 (pt) 1973-07-03
ES288785A1 (es) 1963-11-16

Similar Documents

Publication Publication Date Title
BE616548R (en:Method)
BE629412A (en:Method)
BE631027A (en:Method)
BE634842A (en:Method)
BE634562A (en:Method)
BE634445A (en:Method)
BE634105A (en:Method)
NL293572A (en:Method)
BE633991A (en:Method)
BE633925A (en:Method)
BE633536A (en:Method)
BE633306A (en:Method)
BE632929A (en:Method)
BE632848A (en:Method)
BE632606A (en:Method)
BE632444A (en:Method)
BE631755A (en:Method)
BE631553A (en:Method)
BE630843A (en:Method)
BE627742A (en:Method)
BE626923A (en:Method)
BE626543A (en:Method)
BE624782A (en:Method)
BE622273A (en:Method)
BE617546A (en:Method)